[HTML][HTML] Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature

T Buzgan, MK Karahocagil, H Irmak, AI Baran… - International journal of …, 2010 - Elsevier
INTRODUCTION: Brucellosis is the most prevalent bacterial zoonosis worldwide. In this
study, we aimed to compare our 1028 brucellosis cases with other big series in the literature …

Human brucellosis

MP Franco, M Mulder, RH Gilman… - The Lancet infectious …, 2007 - thelancet.com
Human brucellosis still presents scientists and clinicians with several challenges, such as
the understanding of pathogenic mechanisms of Brucella spp, the identification of markers …

The current therapeutical strategies in human brucellosis

M Bosilkovski, F Keramat, J Arapović - Infection, 2021 - Springer
Prompt and adequate treatment of human brucellosis continues to be the most important
strategy in its management, as eradication of animal brucellosis is not possible so far, and …

Antibiotics for treating human brucellosis

R Yousefi‐Nooraie, S Mortaz‐Hejri… - Cochrane Database …, 2012 - cochranelibrary.com
Background Brucellosis is the most common zoonotic infection in the world. Several
antibiotics, separately or in combination, have been tried for treatment of human brucellosis …

[HTML][HTML] Cell-mediated immunity in human brucellosis

P Skendros, G Pappas, P Boura - Microbes and infection, 2011 - Elsevier
Brucella can parasitize within human antigen-presenting cells modifying phagocytosis,
phagolysosome fusion, antigen presentation, cytokine secretion, and apoptosis. Subversion …

Therapeutic options for human brucellosis

JA Al-Tawfiq - Expert review of anti-infective therapy, 2008 - Taylor & Francis
Worldwide, human brucellosis is the most common zoonotic disease and it has gained
increasing interest because of the potential use of Brucella as a biological weapon …

Future trends in human brucellosis treatment

G Pappas, P Papadimitriou, L Christou… - Expert opinion on …, 2006 - Taylor & Francis
The global burden of human brucellosis remains enormous. Existing treatment options,
largely based on experience gained> 30 years ago, are adequate but not optimal. The …

Prevalencia de la Brucella spp en humanos

CPOC Soares, JAA Teles, AF Santos… - … latino-americana de …, 2015 - SciELO Brasil
Objetivo: determinar la seroprevalencia de la Brucella spp en humanos. Método: se trata de
un estudio observacional, desarrollado con 455 individuos seleccionados con edades entre …

[HTML][HTML] Frequencies of CD4+ T regulatory cells and their CD25high and FoxP3high subsets augment in peripheral blood of patients with acute and chronic …

A Bahador, J Hadjati, N Hassannejad… - Osong public health and …, 2014 - Elsevier
Objectives Brucellosis remains one of the most common zoonotic diseases worldwide. In
humans, brucellosis can be a serious, debilitating, and sometimes chronic disease. Different …

Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment

N Demirtürk, T Demirdal, N Erben, S Demir… - Tropical …, 2008 - journals.sagepub.com
This retrospective study was performed in two university hospitals between January 2002
and 2006. Ninety-nine brucellosis patients were included in the study. These patients were …